GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arntl
|
ENSRNOG00000014448 | aryl hydrocarbon receptor nuclear translocator-like |
Tfe3
|
ENSRNOG00000009605 | transcription factor binding to IGHM enhancer 3 |
Mlx
|
ENSRNOG00000019983 | MLX, MAX dimerization protein |
Mitf
|
ENSRNOG00000008658 | melanogenesis associated transcription factor |
Mlxipl
|
ENSRNOG00000046171 | Mlxipl |
Tfec
|
ENSRNOG00000061595 | transcription factor EC |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Arntl | rn6_v1_chr1_+_178039063_178039063 | -0.31 | 8.9e-09 | Click! |
Mitf | rn6_v1_chr4_+_130172727_130172727 | -0.30 | 7.0e-08 | Click! |
Tfe3 | rn6_v1_chrX_-_15587419_15587419 | -0.29 | 1.4e-07 | Click! |
Mlx | rn6_v1_chr10_+_88997399_88997399 | -0.07 | 2.0e-01 | Click! |
Tfec | rn6_v1_chr4_-_44136815_44136815 | 0.03 | 5.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_243550627 | 56.81 |
ENSRNOT00000085067
ENSRNOT00000083682 |
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr12_+_24367199 | 50.95 |
ENSRNOT00000001971
|
Fkbp6
|
FK506 binding protein 6 |
chr13_+_105408179 | 50.17 |
ENSRNOT00000003378
|
Ddx3y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr2_+_189106039 | 47.87 |
ENSRNOT00000028210
|
Ube2q1
|
ubiquitin conjugating enzyme E2 Q1 |
chr1_+_102849889 | 47.32 |
ENSRNOT00000066791
|
Gtf2h1
|
general transcription factor IIH subunit 1 |
chr13_+_89597138 | 44.60 |
ENSRNOT00000004662
|
Apoa2
|
apolipoprotein A2 |
chr5_+_138470069 | 41.67 |
ENSRNOT00000076343
ENSRNOT00000064073 |
Zmynd12
|
zinc finger, MYND-type containing 12 |
chr3_-_94686989 | 41.12 |
ENSRNOT00000016677
|
Depdc7
|
DEP domain containing 7 |
chr19_+_52225582 | 40.15 |
ENSRNOT00000020917
|
Dnaaf1
|
dynein, axonemal, assembly factor 1 |
chr14_-_3462629 | 38.16 |
ENSRNOT00000061538
|
Brdt
|
bromodomain testis associated |
chr3_+_114176309 | 38.03 |
ENSRNOT00000023350
|
Sord
|
sorbitol dehydrogenase |
chr1_-_88111293 | 35.35 |
ENSRNOT00000077195
|
Spred3
|
sprouty-related, EVH1 domain containing 3 |
chr16_-_81706664 | 35.20 |
ENSRNOT00000026580
|
Lamp1
|
lysosomal-associated membrane protein 1 |
chr5_+_124300477 | 33.14 |
ENSRNOT00000010100
|
C8b
|
complement C8 beta chain |
chr9_+_12633990 | 32.99 |
ENSRNOT00000066517
ENSRNOT00000077532 |
Dazl
|
deleted in azoospermia-like |
chr7_+_144628120 | 31.11 |
ENSRNOT00000022247
|
Hoxc5
|
homeo box C5 |
chr1_-_101773508 | 30.72 |
ENSRNOT00000067430
|
Sult2b1
|
sulfotransferase family 2B member 1 |
chr1_+_261229347 | 30.72 |
ENSRNOT00000018485
|
Ubtd1
|
ubiquitin domain containing 1 |
chr2_+_189400696 | 30.54 |
ENSRNOT00000046919
ENSRNOT00000089801 |
LOC361985
|
similar to NICE-3 |
chr9_+_71398710 | 29.82 |
ENSRNOT00000049411
|
Ccnyl1
|
cyclin Y-like 1 |
chr8_-_113689681 | 29.20 |
ENSRNOT00000056435
|
LOC688828
|
similar to Nucleoside diphosphate-linked moiety X motif 16 (Nudix motif 16) |
chr17_+_85356042 | 28.95 |
ENSRNOT00000022201
|
Commd3
|
COMM domain containing 3 |
chr10_+_14216155 | 28.82 |
ENSRNOT00000020192
|
Hagh
|
hydroxyacyl glutathione hydrolase |
chr16_+_68586235 | 27.45 |
ENSRNOT00000039592
|
LOC103693984
|
uncharacterized LOC103693984 |
chr10_+_84135116 | 27.13 |
ENSRNOT00000031035
|
Hoxb7
|
homeo box B7 |
chr10_+_56546710 | 26.70 |
ENSRNOT00000023003
|
Ybx2
|
Y box binding protein 2 |
chr10_+_109852036 | 26.28 |
ENSRNOT00000054944
|
Aspscr1
|
ASPSCR1, UBX domain containing tether for SLC2A4 |
chr1_+_263554453 | 25.61 |
ENSRNOT00000070861
|
Abcc2
|
ATP binding cassette subfamily C member 2 |
chr5_+_147535525 | 25.58 |
ENSRNOT00000074628
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chr10_+_90984227 | 25.34 |
ENSRNOT00000003890
ENSRNOT00000093707 |
Ccdc103
|
coiled-coil domain containing 103 |
chr20_-_32115310 | 24.95 |
ENSRNOT00000067883
ENSRNOT00000081916 |
Vps26a
|
VPS26 retromer complex component A |
chr15_-_39606003 | 24.81 |
ENSRNOT00000059490
|
RGD1563302
|
RGD1563302 |
chr20_+_46250363 | 24.06 |
ENSRNOT00000076522
ENSRNOT00000000334 |
Cd164
|
CD164 molecule |
chr9_+_10172832 | 23.90 |
ENSRNOT00000074555
|
Acsbg2
|
acyl-CoA synthetase bubblegum family member 2 |
chr1_+_154377447 | 23.77 |
ENSRNOT00000084268
ENSRNOT00000092086 ENSRNOT00000091470 ENSRNOT00000025415 |
Picalm
|
phosphatidylinositol binding clathrin assembly protein |
chr2_+_93803449 | 23.72 |
ENSRNOT00000014949
|
Fabp9
|
fatty acid binding protein 9 |
chr4_-_50200328 | 23.71 |
ENSRNOT00000060530
|
Aass
|
aminoadipate-semialdehyde synthase |
chr12_-_48365784 | 23.28 |
ENSRNOT00000077317
|
Dao
|
D-amino-acid oxidase |
chr11_+_61531416 | 22.68 |
ENSRNOT00000093263
|
Atp6v1a
|
ATPase H+ transporting V1 subunit A |
chr1_+_154377247 | 22.63 |
ENSRNOT00000092945
|
Picalm
|
phosphatidylinositol binding clathrin assembly protein |
chr8_-_132790778 | 22.32 |
ENSRNOT00000008255
ENSRNOT00000091431 |
Lztfl1
|
leucine zipper transcription factor-like 1 |
chr10_+_109851854 | 22.24 |
ENSRNOT00000087005
|
Aspscr1
|
ASPSCR1, UBX domain containing tether for SLC2A4 |
chr10_-_87578854 | 21.84 |
ENSRNOT00000065619
|
LOC680160
|
similar to keratin associated protein 4-7 |
chr4_-_100099517 | 21.44 |
ENSRNOT00000014277
|
Atoh8
|
atonal bHLH transcription factor 8 |
chr2_-_195935878 | 21.34 |
ENSRNOT00000028440
|
Cgn
|
cingulin |
chr2_-_189400323 | 21.06 |
ENSRNOT00000024364
|
Ubap2l
|
ubiquitin associated protein 2-like |
chr14_+_85871597 | 20.92 |
ENSRNOT00000079671
|
Ankrd36
|
ankyrin repeat domain 36 |
chr14_-_19072677 | 20.86 |
ENSRNOT00000060548
|
LOC360919
|
similar to alpha-fetoprotein |
chr1_+_65576535 | 20.71 |
ENSRNOT00000026575
|
Slc27a5
|
solute carrier family 27 member 5 |
chr3_+_161298962 | 20.46 |
ENSRNOT00000066028
|
Ctsa
|
cathepsin A |
chr10_+_4951557 | 20.24 |
ENSRNOT00000003451
|
Prm3
|
protamine 3 |
chr8_-_123371257 | 20.19 |
ENSRNOT00000017243
|
Stt3b
|
STT3B, catalytic subunit of the oligosaccharyltransferase complex |
chr8_-_36760742 | 20.13 |
ENSRNOT00000017307
|
Ddx25
|
DEAD-box helicase 25 |
chr1_+_21525421 | 20.09 |
ENSRNOT00000017911
|
Arg1
|
arginase 1 |
chr6_-_129010271 | 19.92 |
ENSRNOT00000075378
|
Serpina10
|
serpin family A member 10 |
chr1_+_222907159 | 19.74 |
ENSRNOT00000032123
|
Hrasls5
|
HRAS-like suppressor family, member 5 |
chr16_+_74865516 | 19.59 |
ENSRNOT00000058072
|
Atp7b
|
ATPase copper transporting beta |
chr9_+_82345719 | 19.09 |
ENSRNOT00000057330
ENSRNOT00000078260 |
Fam134a
|
family with sequence similarity 134, member A |
chr5_-_147784311 | 18.97 |
ENSRNOT00000074172
|
Fam167b
|
family with sequence similarity 167, member B |
chr9_+_100281339 | 18.90 |
ENSRNOT00000029127
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr1_-_22625204 | 18.72 |
ENSRNOT00000021694
|
Vnn1
|
vanin 1 |
chr9_+_80118029 | 18.66 |
ENSRNOT00000023068
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr12_+_19599834 | 18.46 |
ENSRNOT00000092039
ENSRNOT00000042006 |
Stag3
|
stromal antigen 3 |
chr5_+_73496027 | 18.19 |
ENSRNOT00000022395
|
Actl7a
|
actin-like 7a |
chr3_+_61613774 | 17.99 |
ENSRNOT00000002148
|
Hoxd10
|
homeo box D10 |
chr17_+_76306585 | 17.90 |
ENSRNOT00000065978
|
Dhtkd1
|
dehydrogenase E1 and transketolase domain containing 1 |
chr2_-_182038178 | 17.74 |
ENSRNOT00000040708
|
Fgb
|
fibrinogen beta chain |
chr13_+_84474319 | 17.70 |
ENSRNOT00000031367
ENSRNOT00000072244 ENSRNOT00000072897 ENSRNOT00000064168 ENSRNOT00000074954 ENSRNOT00000073696 |
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr19_+_26106838 | 17.64 |
ENSRNOT00000035987
|
Hook2
|
hook microtubule-tethering protein 2 |
chr7_+_143096874 | 17.62 |
ENSRNOT00000010881
|
RGD1305207
|
similar to RIKEN cDNA 1700011A15 |
chr9_-_43251400 | 17.60 |
ENSRNOT00000037570
|
Fam178b
|
family with sequence similarity 178, member B |
chr7_+_11414446 | 17.47 |
ENSRNOT00000027441
|
Pias4
|
protein inhibitor of activated STAT, 4 |
chr13_-_101163393 | 17.41 |
ENSRNOT00000037997
|
Ccdc185
|
coiled-coil domain containing 185 |
chr12_+_24158766 | 17.18 |
ENSRNOT00000001963
|
Ccl26
|
C-C motif chemokine ligand 26 |
chr18_+_69841053 | 17.18 |
ENSRNOT00000071545
ENSRNOT00000030613 ENSRNOT00000075543 |
Mro
|
maestro |
chr12_+_41600005 | 17.15 |
ENSRNOT00000001872
|
Plbd2
|
phospholipase B domain containing 2 |
chr1_-_252100759 | 17.10 |
ENSRNOT00000028098
|
Rnls
|
renalase, FAD-dependent amine oxidase |
chr6_-_26820959 | 16.99 |
ENSRNOT00000043572
|
Khk
|
ketohexokinase |
chr19_-_25961666 | 16.86 |
ENSRNOT00000004091
|
Calr
|
calreticulin |
chr4_-_82141385 | 16.77 |
ENSRNOT00000008447
|
Hoxa3
|
homeobox A3 |
chr19_+_58505811 | 16.55 |
ENSRNOT00000031717
|
Map10
|
microtubule-associated protein 10 |
chr3_-_8852192 | 16.53 |
ENSRNOT00000022786
|
Dolk
|
dolichol kinase |
chr12_+_16912249 | 16.38 |
ENSRNOT00000085936
|
Tmem184a
|
transmembrane protein 184A |
chr7_-_130451283 | 16.35 |
ENSRNOT00000017783
|
Arsa
|
arylsulfatase A |
chr8_-_115981910 | 16.14 |
ENSRNOT00000019867
|
Dock3
|
dedicator of cyto-kinesis 3 |
chr11_-_34598102 | 16.08 |
ENSRNOT00000068743
|
Pigp
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr1_-_102849430 | 15.98 |
ENSRNOT00000086856
|
Saa4
|
serum amyloid A4 |
chr3_-_148428494 | 15.81 |
ENSRNOT00000011350
|
Dusp15
|
dual specificity phosphatase 15 |
chr4_-_82271893 | 15.76 |
ENSRNOT00000075005
|
Hoxa7
|
homeobox A7 |
chr9_-_27447877 | 15.65 |
ENSRNOT00000085195
|
Gsta1
|
glutathione S-transferase alpha 1 |
chr4_+_57926531 | 15.64 |
ENSRNOT00000013948
|
Cpa5
|
carboxypeptidase A5 |
chr10_+_59765258 | 15.61 |
ENSRNOT00000026351
|
Shpk
|
sedoheptulokinase |
chrX_+_74497262 | 15.54 |
ENSRNOT00000003899
|
Zcchc13
|
zinc finger CCHC-type containing 13 |
chr11_+_61531571 | 15.45 |
ENSRNOT00000093467
ENSRNOT00000002727 |
Atp6v1a
|
ATPase H+ transporting V1 subunit A |
chr15_-_39573776 | 15.37 |
ENSRNOT00000082517
|
LOC691850
|
hypothetical protein LOC691850 |
chr13_-_91427575 | 15.25 |
ENSRNOT00000012092
|
Apcs
|
amyloid P component, serum |
chr1_-_197997664 | 15.16 |
ENSRNOT00000025898
|
Cln3
|
ceroid-lipofuscinosis, neuronal 3 |
chr8_-_23014499 | 15.15 |
ENSRNOT00000017820
|
Ccdc151
|
coiled-coil domain containing 151 |
chr5_+_171242897 | 15.02 |
ENSRNOT00000032859
|
RGD1304567
|
similar to RIKEN cDNA A430005L14 |
chr13_-_74005486 | 14.79 |
ENSRNOT00000090173
|
AABR07021465.1
|
|
chr16_-_47163898 | 14.60 |
ENSRNOT00000074490
|
Ccdc110
|
coiled-coil domain containing 110 |
chr5_-_58163584 | 14.60 |
ENSRNOT00000060594
|
Ccl27
|
C-C motif chemokine ligand 27 |
chr9_-_50820290 | 14.53 |
ENSRNOT00000050748
|
LOC102548013
|
uncharacterized LOC102548013 |
chr18_+_55797198 | 14.27 |
ENSRNOT00000026334
ENSRNOT00000026394 |
Dctn4
|
dynactin subunit 4 |
chr8_-_111107599 | 14.25 |
ENSRNOT00000031313
|
Cep63
|
centrosomal protein 63 |
chr2_+_127538659 | 14.16 |
ENSRNOT00000093483
ENSRNOT00000058476 |
Slc25a31
|
solute carrier family 25 member 31 |
chr2_+_114423533 | 14.14 |
ENSRNOT00000091221
|
Slc2a2
|
solute carrier family 2 member 2 |
chr14_-_89238094 | 14.14 |
ENSRNOT00000006818
|
Sun3
|
Sad1 and UNC84 domain containing 3 |
chr8_+_64325435 | 14.07 |
ENSRNOT00000013747
|
Hexa
|
hexosaminidase subunit alpha |
chr13_+_109646455 | 14.01 |
ENSRNOT00000073985
|
LOC498316
|
hypothetical LOC498316 |
chr3_+_61604672 | 13.92 |
ENSRNOT00000080456
|
Hoxd11
|
homeobox D11 |
chr16_+_8497569 | 13.86 |
ENSRNOT00000027054
|
Ogdhl
|
oxoglutarate dehydrogenase-like |
chr9_-_10170428 | 13.81 |
ENSRNOT00000073048
|
LOC316124
|
similar to gonadotropin-regulated long chain acyl-CoA synthetase |
chr5_-_32956159 | 13.80 |
ENSRNOT00000078264
|
Cnbd1
|
cyclic nucleotide binding domain containing 1 |
chr5_-_104920906 | 13.77 |
ENSRNOT00000071318
|
Fam154a
|
family with sequence similarity 154, member A |
chr7_-_120559157 | 13.75 |
ENSRNOT00000090565
ENSRNOT00000016827 ENSRNOT00000017108 |
Pla2g6
|
phospholipase A2 group VI |
chr9_-_100624638 | 13.71 |
ENSRNOT00000051155
|
Hdlbp
|
high density lipoprotein binding protein |
chrX_+_13992064 | 13.70 |
ENSRNOT00000036543
|
LOC100363125
|
rCG42854-like |
chr11_+_74057361 | 13.69 |
ENSRNOT00000048746
|
Cpn2
|
carboxypeptidase N subunit 2 |
chr3_-_33075685 | 13.62 |
ENSRNOT00000006937
|
Orc4
|
origin recognition complex, subunit 4 |
chr10_-_35058870 | 13.60 |
ENSRNOT00000079481
|
AABR07029573.3
|
|
chr17_-_43584152 | 13.51 |
ENSRNOT00000023241
|
Slc17a2
|
solute carrier family 17, member 2 |
chr18_-_37245809 | 13.49 |
ENSRNOT00000079585
|
Ppp2r2b
|
protein phosphatase 2, regulatory subunit B, beta |
chr3_+_163570532 | 13.48 |
ENSRNOT00000010054
|
Arfgef2
|
ADP ribosylation factor guanine nucleotide exchange factor 2 |
chr12_-_21832813 | 13.42 |
ENSRNOT00000075280
|
Cldn3
|
claudin 3 |
chr8_-_85645718 | 13.39 |
ENSRNOT00000032185
|
Gsta2
|
glutathione S-transferase alpha 2 |
chr10_+_65780494 | 13.39 |
ENSRNOT00000013100
|
Poldip2
|
DNA polymerase delta interacting protein 2 |
chr17_-_417480 | 13.36 |
ENSRNOT00000023685
|
Fbp1
|
fructose-bisphosphatase 1 |
chr1_-_80599572 | 13.31 |
ENSRNOT00000024832
|
Apoc4
|
apolipoprotein C4 |
chr19_+_52077501 | 13.27 |
ENSRNOT00000079240
|
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr10_+_10725819 | 13.24 |
ENSRNOT00000004159
|
Glyr1
|
glyoxylate reductase 1 homolog |
chr3_+_171597241 | 13.19 |
ENSRNOT00000029558
|
LOC689618
|
similar to Protein C20orf85 homolog |
chr1_-_250951697 | 13.11 |
ENSRNOT00000054761
|
Sgms1
|
sphingomyelin synthase 1 |
chr2_-_187622373 | 12.99 |
ENSRNOT00000026396
|
Rhbg
|
Rh family B glycoprotein |
chr10_-_44746549 | 12.87 |
ENSRNOT00000003841
|
Fam183b
|
family with sequence similarity 183, member B |
chr4_+_148286858 | 12.75 |
ENSRNOT00000017294
ENSRNOT00000092294 ENSRNOT00000092477 |
March8
|
membrane associated ring-CH-type finger 8 |
chr2_-_211017778 | 12.68 |
ENSRNOT00000026883
|
Sypl2
|
synaptophysin-like 2 |
chr14_+_22724070 | 12.65 |
ENSRNOT00000089471
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr11_-_34598275 | 12.58 |
ENSRNOT00000077233
|
Pigp
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr1_+_196737627 | 12.56 |
ENSRNOT00000066652
|
LOC100271845
|
hypothetical protein LOC100271845 |
chr2_+_208541361 | 12.44 |
ENSRNOT00000021288
|
Tmigd3
|
transmembrane and immunoglobulin domain containing 3 |
chr12_+_37593874 | 12.42 |
ENSRNOT00000057902
|
Sbno1
|
strawberry notch homolog 1 |
chr17_+_54280851 | 12.41 |
ENSRNOT00000024022
|
Arhgap12
|
Rho GTPase activating protein 12 |
chr2_+_147006830 | 12.36 |
ENSRNOT00000080780
|
AABR07010672.1
|
|
chrX_-_106558366 | 12.25 |
ENSRNOT00000042126
|
Bex2
|
brain expressed X-linked 2 |
chr7_+_94130852 | 12.22 |
ENSRNOT00000011485
|
Mal2
|
mal, T-cell differentiation protein 2 |
chrX_+_74200972 | 12.18 |
ENSRNOT00000076956
|
Chic1
|
cysteine-rich hydrophobic domain 1 |
chr7_+_38945836 | 12.18 |
ENSRNOT00000006455
|
Ccer1
|
coiled-coil glutamate-rich protein 1 |
chr17_-_9837293 | 12.14 |
ENSRNOT00000091320
ENSRNOT00000022134 |
Prelid1
|
PRELI domain containing 1 |
chr3_+_61658245 | 12.14 |
ENSRNOT00000033511
|
Hoxd3
|
homeo box D3 |
chr10_+_40543288 | 12.13 |
ENSRNOT00000016755
|
Slc36a1
|
solute carrier family 36 member 1 |
chr19_-_42180362 | 12.11 |
ENSRNOT00000089515
|
Pmfbp1
|
polyamine modulated factor 1 binding protein 1 |
chr15_+_28319136 | 12.10 |
ENSRNOT00000048723
|
Tppp2
|
tubulin polymerization-promoting protein family member 2 |
chr7_+_70980422 | 12.05 |
ENSRNOT00000077912
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr10_-_94988461 | 12.01 |
ENSRNOT00000048490
|
Ddx5
|
DEAD-box helicase 5 |
chr7_-_120558805 | 11.99 |
ENSRNOT00000087344
|
Pla2g6
|
phospholipase A2 group VI |
chr1_+_188288738 | 11.92 |
ENSRNOT00000055103
|
Tmc5
|
transmembrane channel-like 5 |
chr13_+_70852023 | 11.90 |
ENSRNOT00000003661
|
Shcbp1l
|
SHC binding and spindle associated 1 like |
chr1_-_48559162 | 11.86 |
ENSRNOT00000080352
|
Plg
|
plasminogen |
chr2_+_243820661 | 11.80 |
ENSRNOT00000090526
|
Eif4e
|
eukaryotic translation initiation factor 4E |
chr14_-_10446909 | 11.78 |
ENSRNOT00000002962
|
Mrps18c
|
mitochondrial ribosomal protein S18C |
chr19_-_37370429 | 11.70 |
ENSRNOT00000022497
|
Kctd19
|
potassium channel tetramerization domain containing 19 |
chr2_-_60683451 | 11.70 |
ENSRNOT00000046215
|
Rai14
|
retinoic acid induced 14 |
chr1_-_259287684 | 11.67 |
ENSRNOT00000054724
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22 |
chr19_-_10826895 | 11.59 |
ENSRNOT00000090217
|
Rspry1
|
ring finger and SPRY domain containing 1 |
chr1_-_91462603 | 11.58 |
ENSRNOT00000015384
|
Lrp3
|
LDL receptor related protein 3 |
chr13_+_99335020 | 11.49 |
ENSRNOT00000029787
|
AABR07021930.1
|
|
chrX_-_54303729 | 11.49 |
ENSRNOT00000087919
ENSRNOT00000064340 ENSRNOT00000051249 ENSRNOT00000087547 |
Gk
|
glycerol kinase |
chr17_+_45175121 | 11.37 |
ENSRNOT00000080417
|
Nkapl
|
NFKB activating protein-like |
chr6_+_52702544 | 11.36 |
ENSRNOT00000014252
|
Efcab10
|
EF-hand calcium binding domain 10 |
chr14_-_44767120 | 11.25 |
ENSRNOT00000003991
|
Wdr19
|
WD repeat domain 19 |
chr17_+_78793336 | 11.18 |
ENSRNOT00000057898
|
Mt1
|
metallothionein 1 |
chr7_-_120874308 | 11.09 |
ENSRNOT00000078320
|
Fam227a
|
family with sequence similarity 227, member A |
chr3_+_79678201 | 11.09 |
ENSRNOT00000087604
ENSRNOT00000079709 |
Mtch2
|
mitochondrial carrier 2 |
chr10_-_6870011 | 11.05 |
ENSRNOT00000003439
|
RGD1309748
|
similar to CG4768-PA |
chr10_+_93305969 | 11.05 |
ENSRNOT00000008019
|
Efcab3
|
EF-hand calcium binding domain 3 |
chr12_+_37594185 | 10.98 |
ENSRNOT00000088787
|
Sbno1
|
strawberry notch homolog 1 |
chr10_+_71202456 | 10.96 |
ENSRNOT00000076893
|
Hnf1b
|
HNF1 homeobox B |
chr1_-_54748763 | 10.94 |
ENSRNOT00000074549
|
LOC100911027
|
protein MAL2-like |
chr11_-_81444375 | 10.91 |
ENSRNOT00000058479
ENSRNOT00000078131 ENSRNOT00000080949 ENSRNOT00000080562 ENSRNOT00000084867 |
Kng1
|
kininogen 1 |
chr17_+_16333415 | 10.91 |
ENSRNOT00000060550
|
Ptpdc1
|
protein tyrosine phosphatase domain containing 1 |
chr5_-_9429859 | 10.82 |
ENSRNOT00000009462
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1 |
chr19_+_52077109 | 10.82 |
ENSRNOT00000020225
|
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chrX_-_105308554 | 10.78 |
ENSRNOT00000045556
|
Taf7l
|
TATA-box binding protein associated factor 7-like |
chr2_+_60337667 | 10.76 |
ENSRNOT00000024035
|
Agxt2
|
alanine-glyoxylate aminotransferase 2 |
chr5_+_133896141 | 10.75 |
ENSRNOT00000011434
|
Pdzk1ip1
|
PDZK1 interacting protein 1 |
chr2_-_173563273 | 10.74 |
ENSRNOT00000081423
|
Zbbx
|
zinc finger, B-box domain containing |
chr10_+_97647111 | 10.73 |
ENSRNOT00000055062
|
Gna13
|
G protein subunit alpha 13 |
chrX_-_105793306 | 10.73 |
ENSRNOT00000015806
|
Nxf2
|
nuclear RNA export factor 2 |
chr9_-_80295446 | 10.65 |
ENSRNOT00000023769
|
Tnp1
|
transition protein 1 |
chr11_+_52828116 | 10.60 |
ENSRNOT00000035340
|
Ccdc54
|
coiled-coil domain containing 54 |
chr1_+_100086520 | 10.60 |
ENSRNOT00000025723
|
Klk1
|
kallikrein 1 |
chr14_+_22375955 | 10.60 |
ENSRNOT00000063915
ENSRNOT00000034784 |
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr7_-_12673659 | 10.59 |
ENSRNOT00000091650
ENSRNOT00000041277 ENSRNOT00000044865 |
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr3_-_23066658 | 10.58 |
ENSRNOT00000018751
|
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1 |
chr5_+_124442293 | 10.51 |
ENSRNOT00000041922
|
RGD1564074
|
similar to novel protein |
chr1_+_224800252 | 10.49 |
ENSRNOT00000024488
|
Slc22a8
|
solute carrier family 22 member 8 |
chr6_-_50846965 | 10.46 |
ENSRNOT00000087300
|
Slc26a4
|
solute carrier family 26 member 4 |
chr10_+_62981297 | 10.41 |
ENSRNOT00000031618
|
Efcab5
|
EF-hand calcium binding domain 5 |
chr2_-_198852161 | 10.39 |
ENSRNOT00000028815
|
Polr3c
|
RNA polymerase III subunit C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.6 | 61.8 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
15.5 | 46.4 | GO:1902962 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
14.9 | 44.6 | GO:0046340 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) diacylglycerol catabolic process(GO:0046340) |
14.7 | 44.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
12.2 | 36.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
11.7 | 35.2 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
10.9 | 54.4 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
7.9 | 23.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
7.2 | 28.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
6.8 | 68.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
6.5 | 19.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
6.4 | 25.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
6.4 | 25.6 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
6.2 | 18.7 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
6.0 | 23.8 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
5.8 | 28.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
5.6 | 16.9 | GO:0002397 | MHC class I protein complex assembly(GO:0002397) |
5.6 | 11.2 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
5.5 | 22.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
5.5 | 16.4 | GO:0000053 | argininosuccinate metabolic process(GO:0000053) |
5.2 | 41.9 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
5.1 | 15.3 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) adenosine biosynthetic process(GO:0046086) |
5.0 | 15.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
4.9 | 19.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
4.9 | 44.0 | GO:0070459 | prolactin secretion(GO:0070459) |
4.6 | 13.9 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
4.6 | 32.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
4.5 | 17.8 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
4.4 | 17.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
4.3 | 13.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.1 | 12.3 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
4.1 | 16.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.1 | 16.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
4.1 | 20.3 | GO:0015755 | fructose transport(GO:0015755) |
4.0 | 12.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
4.0 | 20.1 | GO:0010958 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
4.0 | 20.1 | GO:1904640 | response to methionine(GO:1904640) |
4.0 | 11.9 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
3.9 | 11.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
3.9 | 38.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
3.9 | 11.6 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) |
3.8 | 11.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
3.8 | 11.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
3.7 | 11.0 | GO:0061215 | mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
3.5 | 17.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.5 | 59.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
3.5 | 10.5 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
3.4 | 20.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.4 | 13.5 | GO:0006565 | L-serine catabolic process(GO:0006565) |
3.4 | 13.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
3.3 | 13.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
3.3 | 13.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
3.3 | 9.9 | GO:0051977 | lysophospholipid transport(GO:0051977) |
3.2 | 22.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
3.1 | 15.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
3.1 | 37.3 | GO:0007135 | meiosis II(GO:0007135) |
3.0 | 8.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
3.0 | 17.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
2.9 | 2.9 | GO:0009758 | carbohydrate utilization(GO:0009758) |
2.9 | 8.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
2.9 | 5.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.8 | 8.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.8 | 11.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
2.8 | 11.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) myotome development(GO:0061055) |
2.8 | 8.4 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
2.8 | 11.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
2.8 | 22.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.8 | 13.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
2.8 | 13.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
2.8 | 8.3 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
2.6 | 7.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
2.6 | 18.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.6 | 10.3 | GO:0015879 | carnitine transport(GO:0015879) |
2.5 | 15.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.5 | 7.6 | GO:0090487 | toxin catabolic process(GO:0009407) mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound catabolic process(GO:1901377) |
2.5 | 12.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.5 | 34.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
2.5 | 12.4 | GO:1904970 | brush border assembly(GO:1904970) |
2.5 | 7.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
2.5 | 7.4 | GO:0071282 | cellular response to iron(II) ion(GO:0071282) |
2.5 | 12.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
2.5 | 12.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.4 | 4.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.4 | 9.7 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
2.4 | 33.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
2.4 | 4.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.4 | 7.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.4 | 7.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.4 | 16.5 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
2.4 | 21.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
2.3 | 18.7 | GO:0015705 | iodide transport(GO:0015705) |
2.3 | 7.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
2.3 | 76.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
2.3 | 25.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
2.3 | 4.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.3 | 15.9 | GO:0015808 | L-alanine transport(GO:0015808) |
2.3 | 9.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
2.2 | 6.7 | GO:0032218 | riboflavin transport(GO:0032218) |
2.2 | 24.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.2 | 6.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.2 | 6.6 | GO:0006214 | thymidine catabolic process(GO:0006214) pyrimidine deoxyribonucleoside catabolic process(GO:0046127) |
2.2 | 17.5 | GO:0051182 | coenzyme transport(GO:0051182) |
2.1 | 44.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
2.1 | 6.3 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
2.1 | 6.2 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
2.1 | 8.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
2.1 | 10.3 | GO:1902224 | ketone body metabolic process(GO:1902224) |
2.1 | 8.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
2.0 | 20.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.0 | 10.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.0 | 8.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.0 | 5.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
2.0 | 4.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.0 | 15.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
2.0 | 9.8 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.9 | 9.7 | GO:0015889 | cobalamin transport(GO:0015889) |
1.9 | 19.4 | GO:0015886 | heme transport(GO:0015886) |
1.9 | 3.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.9 | 13.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.8 | 32.6 | GO:0001675 | acrosome assembly(GO:0001675) |
1.8 | 23.2 | GO:0098880 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of postsynaptic density structure(GO:0099562) |
1.8 | 16.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.8 | 1.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
1.8 | 5.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
1.7 | 5.2 | GO:0071529 | cementum mineralization(GO:0071529) |
1.7 | 12.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.7 | 8.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.7 | 32.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
1.7 | 3.4 | GO:0006788 | heme oxidation(GO:0006788) |
1.7 | 5.1 | GO:0006562 | proline catabolic process(GO:0006562) |
1.7 | 6.8 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
1.7 | 8.4 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
1.7 | 3.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
1.7 | 3.3 | GO:0060460 | left lung morphogenesis(GO:0060460) |
1.7 | 23.3 | GO:0045056 | transcytosis(GO:0045056) |
1.6 | 3.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.6 | 4.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
1.6 | 18.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.6 | 4.9 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.6 | 4.9 | GO:2000611 | basement membrane disassembly(GO:0034769) positive regulation of thyroid hormone generation(GO:2000611) |
1.6 | 30.9 | GO:0051450 | myoblast proliferation(GO:0051450) |
1.6 | 4.9 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
1.6 | 4.8 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
1.6 | 28.8 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
1.6 | 6.4 | GO:0030576 | Cajal body organization(GO:0030576) |
1.6 | 6.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.6 | 20.5 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.6 | 3.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.6 | 10.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.6 | 3.1 | GO:0043132 | NAD transport(GO:0043132) |
1.5 | 9.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.5 | 12.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.5 | 10.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.5 | 13.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.5 | 10.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.5 | 18.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
1.5 | 6.0 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
1.5 | 6.0 | GO:0018963 | phthalate metabolic process(GO:0018963) |
1.5 | 4.4 | GO:1902211 | regulation of prolactin signaling pathway(GO:1902211) |
1.5 | 10.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
1.4 | 4.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.4 | 12.8 | GO:0007097 | nuclear migration(GO:0007097) |
1.4 | 107.5 | GO:0030317 | sperm motility(GO:0030317) |
1.4 | 8.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
1.4 | 2.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.4 | 5.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
1.3 | 13.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.3 | 2.7 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
1.3 | 3.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.3 | 3.9 | GO:1990743 | protein sialylation(GO:1990743) |
1.3 | 6.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.3 | 5.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 9.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
1.3 | 5.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.3 | 6.4 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
1.3 | 7.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.3 | 53.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.3 | 5.1 | GO:1990962 | carbohydrate export(GO:0033231) daunorubicin transport(GO:0043215) response to borneol(GO:1905230) cellular response to borneol(GO:1905231) response to codeine(GO:1905233) response to quercetin(GO:1905235) drug transport across blood-brain barrier(GO:1990962) establishment of blood-retinal barrier(GO:1990963) |
1.2 | 2.5 | GO:0072179 | kidney rudiment formation(GO:0072003) nephric duct formation(GO:0072179) |
1.2 | 3.7 | GO:0060166 | olfactory pit development(GO:0060166) |
1.2 | 3.7 | GO:0010034 | response to acetate(GO:0010034) |
1.2 | 4.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.2 | 3.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.2 | 7.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.2 | 3.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.2 | 3.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.1 | 2.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.1 | 6.8 | GO:0032439 | endosome localization(GO:0032439) |
1.1 | 3.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.1 | 2.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.1 | 3.4 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
1.1 | 3.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 4.5 | GO:0036233 | glycine import(GO:0036233) |
1.1 | 13.2 | GO:0042730 | fibrinolysis(GO:0042730) |
1.1 | 3.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.1 | 15.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.1 | 8.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.1 | 16.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.1 | 13.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.1 | 4.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 8.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
1.0 | 21.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.0 | 26.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.0 | 15.6 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.0 | 9.2 | GO:0007343 | egg activation(GO:0007343) |
1.0 | 3.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
1.0 | 20.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.0 | 3.0 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.0 | 3.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.0 | 4.9 | GO:1903352 | mitochondrial ornithine transport(GO:0000066) L-ornithine transmembrane transport(GO:1903352) |
1.0 | 2.0 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
1.0 | 22.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.0 | 2.9 | GO:0015811 | L-cystine transport(GO:0015811) |
1.0 | 1.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
1.0 | 6.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.0 | 7.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.0 | 3.8 | GO:0035106 | operant conditioning(GO:0035106) |
0.9 | 3.7 | GO:0098705 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.9 | 0.9 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.9 | 3.6 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
0.9 | 103.5 | GO:0007286 | spermatid development(GO:0007286) |
0.9 | 3.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.9 | 2.7 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.9 | 2.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.9 | 8.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.9 | 3.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.9 | 0.9 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.9 | 7.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.9 | 8.8 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.9 | 2.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.9 | 5.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.9 | 6.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.9 | 9.5 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.9 | 17.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.9 | 2.6 | GO:2000338 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.9 | 6.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.9 | 3.4 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
0.9 | 2.6 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 2.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.9 | 3.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 2.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) positive regulation of actin filament-based movement(GO:1903116) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.8 | 47.8 | GO:0007129 | synapsis(GO:0007129) |
0.8 | 1.7 | GO:0010157 | response to chlorate(GO:0010157) |
0.8 | 2.5 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.8 | 4.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.8 | 3.3 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.8 | 10.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.8 | 3.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.8 | 3.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.8 | 8.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.8 | 4.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.8 | 4.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.8 | 2.4 | GO:0006574 | valine catabolic process(GO:0006574) |
0.8 | 3.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.8 | 11.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.8 | 0.8 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.8 | 6.9 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.8 | 9.9 | GO:0042407 | cristae formation(GO:0042407) |
0.8 | 16.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 4.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 21.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.7 | 1.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 4.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 2.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.7 | 4.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.7 | 1.5 | GO:0031427 | response to methotrexate(GO:0031427) |
0.7 | 5.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 8.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 6.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 7.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.7 | 2.2 | GO:0060816 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.7 | 1.4 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
0.7 | 2.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.7 | 12.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.7 | 2.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.7 | 9.9 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.7 | 6.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.7 | 4.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.7 | 1.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 3.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.7 | 6.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.7 | 3.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.7 | 2.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.7 | 1.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.7 | 2.6 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.6 | 22.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.6 | 2.6 | GO:1904975 | response to bleomycin(GO:1904975) |
0.6 | 3.2 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) |
0.6 | 3.1 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.6 | 1.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.6 | 12.1 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.6 | 3.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 2.4 | GO:0006538 | glutamate biosynthetic process(GO:0006537) glutamate catabolic process(GO:0006538) |
0.6 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 5.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.6 | 5.3 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.6 | 2.9 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
0.6 | 11.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.6 | 3.5 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.6 | 1.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.6 | 1.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.6 | 2.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.6 | 3.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.6 | 4.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.6 | 3.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 2.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 19.9 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.5 | 3.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 2.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 3.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.5 | 12.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 1.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 2.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 4.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.5 | 2.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 1.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 9.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.5 | 3.0 | GO:2000809 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.5 | 6.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.5 | 2.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.5 | 12.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 1.5 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.5 | 4.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.5 | 5.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.5 | 5.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 1.9 | GO:0016240 | autophagosome docking(GO:0016240) |
0.5 | 10.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 1.9 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.5 | 2.4 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 0.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 15.7 | GO:0007032 | endosome organization(GO:0007032) |
0.5 | 3.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 18.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.5 | 7.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.5 | 1.4 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.4 | 0.9 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 4.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.4 | 2.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) threonine catabolic process(GO:0006567) |
0.4 | 2.2 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
0.4 | 4.7 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.4 | 1.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 2.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.4 | 1.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.4 | 3.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 5.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 3.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 2.0 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 9.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.4 | 3.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.4 | 3.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.4 | 1.9 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 7.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 1.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 11.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 2.5 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 3.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 4.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.4 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) negative regulation of vitamin metabolic process(GO:0046137) cellular response to prolactin(GO:1990646) |
0.4 | 1.8 | GO:0060327 | Cdc42 protein signal transduction(GO:0032488) cytoplasmic actin-based contraction involved in cell motility(GO:0060327) |
0.3 | 1.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 3.8 | GO:0009635 | response to herbicide(GO:0009635) |
0.3 | 4.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 2.7 | GO:0061734 | negative regulation of receptor recycling(GO:0001920) parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.3 | 1.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.3 | 1.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.7 | GO:0030186 | melatonin metabolic process(GO:0030186) |
0.3 | 3.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 0.6 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.3 | 6.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 2.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 2.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.9 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.3 | 1.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.3 | 4.6 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.3 | 1.8 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.3 | 0.6 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.3 | 1.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 2.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 3.9 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 0.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 18.8 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.3 | 0.9 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) dipeptide transport(GO:0042938) |
0.3 | 5.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 3.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 5.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.3 | 1.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 9.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 1.2 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 1.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 7.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 4.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 3.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 7.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 0.5 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.3 | 13.5 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.3 | 1.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 4.7 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 1.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.8 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.3 | 0.8 | GO:0002458 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) positive regulation of immature T cell proliferation in thymus(GO:0033092) negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.3 | 1.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.3 | 0.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 3.9 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.3 | 4.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 1.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.2 | 6.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.2 | 3.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 1.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.2 | 3.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 1.2 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 1.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.9 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
0.2 | 0.9 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.8 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 1.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 19.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 2.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 9.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 1.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 2.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 2.2 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 2.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.2 | 1.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.9 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 2.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 2.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 10.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 1.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.6 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 2.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 2.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 1.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 1.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.2 | 10.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 4.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 1.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 2.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 1.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 2.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 16.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 0.6 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 3.4 | GO:0001964 | startle response(GO:0001964) |
0.2 | 2.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 0.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 5.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 6.3 | GO:0031016 | pancreas development(GO:0031016) |
0.2 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.3 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.2 | 47.8 | GO:0007283 | spermatogenesis(GO:0007283) |
0.2 | 1.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.0 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 0.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 0.6 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 1.4 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 2.5 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 1.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 1.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 4.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 2.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 3.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 5.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 3.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 3.7 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 1.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 3.6 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.2 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 6.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 1.3 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 0.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 2.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 1.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 1.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 1.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 2.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.0 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 2.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 0.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.7 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 1.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 3.4 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.7 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 4.7 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 0.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.3 | GO:0072525 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) pyridine-containing compound biosynthetic process(GO:0072525) |
0.1 | 5.5 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 1.9 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.2 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) |
0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 1.6 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 1.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.8 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.5 | GO:0098789 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.3 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.9 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.5 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.1 | 0.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 2.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.9 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.2 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 56.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 1.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 1.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.3 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.0 | 1.0 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.4 | GO:0051590 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.8 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.0 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0032919 | spermine acetylation(GO:0032919) |
0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:2000687 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.4 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 35.2 | GO:0061474 | phagolysosome membrane(GO:0061474) |
6.5 | 26.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
6.4 | 31.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
6.2 | 18.5 | GO:0000802 | transverse filament(GO:0000802) |
5.7 | 45.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
5.6 | 50.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
5.5 | 38.5 | GO:0005579 | membrane attack complex(GO:0005579) |
5.4 | 48.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
5.2 | 26.1 | GO:0070695 | FHF complex(GO:0070695) |
4.5 | 54.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
4.2 | 16.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
4.0 | 11.9 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.2 | 25.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
3.0 | 26.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.9 | 8.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
2.8 | 33.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
2.8 | 8.3 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
2.5 | 17.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.5 | 32.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.5 | 17.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.4 | 48.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.2 | 6.5 | GO:0031309 | intrinsic component of nuclear outer membrane(GO:0031308) integral component of nuclear outer membrane(GO:0031309) |
2.2 | 12.9 | GO:0032280 | symmetric synapse(GO:0032280) |
2.0 | 20.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
2.0 | 7.9 | GO:0034774 | secretory granule lumen(GO:0034774) |
1.9 | 13.6 | GO:0071203 | WASH complex(GO:0071203) |
1.9 | 7.4 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
1.8 | 5.5 | GO:1990037 | Lewy body core(GO:1990037) |
1.8 | 14.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.8 | 16.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.8 | 25.0 | GO:0072687 | meiotic spindle(GO:0072687) |
1.8 | 14.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.7 | 30.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.7 | 76.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
1.6 | 11.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.6 | 8.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.5 | 13.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 5.7 | GO:0008091 | spectrin(GO:0008091) |
1.4 | 74.2 | GO:0005844 | polysome(GO:0005844) |
1.4 | 9.9 | GO:0061617 | MICOS complex(GO:0061617) |
1.4 | 8.4 | GO:1990246 | uniplex complex(GO:1990246) |
1.4 | 9.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.4 | 23.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.3 | 13.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 20.1 | GO:0033391 | chromatoid body(GO:0033391) |
1.2 | 12.5 | GO:0045179 | apical cortex(GO:0045179) |
1.2 | 17.3 | GO:0070852 | cell body fiber(GO:0070852) |
1.2 | 102.8 | GO:0031526 | brush border membrane(GO:0031526) |
1.2 | 19.2 | GO:0001520 | outer dense fiber(GO:0001520) |
1.2 | 8.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.2 | 24.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.1 | 17.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.1 | 21.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.1 | 4.5 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
1.1 | 22.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.1 | 23.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.1 | 3.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.0 | 26.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.0 | 2.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.9 | 5.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.9 | 2.7 | GO:0042627 | chylomicron(GO:0042627) |
0.9 | 3.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.9 | 4.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.9 | 95.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.9 | 7.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.9 | 4.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 1.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 7.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.9 | 6.0 | GO:0002177 | manchette(GO:0002177) |
0.9 | 2.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.8 | 9.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.8 | 15.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.8 | 4.0 | GO:1903768 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
0.8 | 99.6 | GO:0031514 | motile cilium(GO:0031514) |
0.8 | 2.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 48.9 | GO:0044439 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.7 | 3.7 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 50.4 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.7 | 2.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.7 | 4.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.7 | 13.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.7 | 2.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.7 | 15.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 2.6 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.6 | 10.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.6 | 3.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.6 | 9.4 | GO:0036038 | MKS complex(GO:0036038) |
0.6 | 4.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 10.0 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 3.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 1.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 2.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 5.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 3.1 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 13.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 1.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 1.9 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.5 | 7.4 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 145.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 1.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 0.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.4 | 51.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.4 | 25.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 4.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 5.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 47.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 2.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 3.5 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 22.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 2.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 28.1 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 6.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 5.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 34.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 4.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 8.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 2.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 7.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.4 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 2.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.1 | GO:0032044 | DSIF complex(GO:0032044) |
0.3 | 0.8 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.2 | 41.1 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.2 | 11.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 6.7 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 3.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 4.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.9 | GO:0048788 | cytoskeleton of presynaptic active zone(GO:0048788) |
0.2 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 3.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 9.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 9.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 1.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 0.9 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 1.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 5.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 13.7 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 4.6 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.1 | GO:0070449 | elongin complex(GO:0070449) |
0.2 | 1.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 4.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 4.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 2.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 5.5 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 5.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 34.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 8.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 4.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 11.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 5.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 3.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 2.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 29.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 1.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 44.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
12.4 | 49.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
12.2 | 73.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
10.6 | 31.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
6.8 | 34.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
6.2 | 18.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
5.8 | 28.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
5.7 | 17.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
5.4 | 21.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
5.4 | 10.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
5.3 | 16.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
5.2 | 46.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
5.1 | 35.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
4.7 | 28.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
4.6 | 18.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
4.5 | 13.5 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
4.0 | 20.2 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
4.0 | 51.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
3.8 | 11.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
3.8 | 45.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.7 | 18.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
3.6 | 10.8 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
3.6 | 10.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.5 | 10.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.5 | 31.6 | GO:0008494 | translation activator activity(GO:0008494) |
3.3 | 26.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
3.3 | 13.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
3.2 | 9.7 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
3.2 | 9.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
3.1 | 12.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
2.9 | 61.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
2.9 | 8.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
2.8 | 11.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
2.8 | 13.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
2.7 | 13.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.7 | 34.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.7 | 8.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.6 | 13.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
2.6 | 10.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.6 | 15.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.6 | 25.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.6 | 7.7 | GO:0000703 | oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity(GO:0000703) |
2.5 | 22.7 | GO:0046790 | virion binding(GO:0046790) |
2.5 | 22.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.5 | 9.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
2.5 | 7.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
2.4 | 12.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
2.4 | 9.5 | GO:0030984 | kininogen binding(GO:0030984) |
2.4 | 42.5 | GO:0043295 | glutathione binding(GO:0043295) |
2.3 | 9.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
2.2 | 6.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
2.2 | 44.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
2.2 | 6.6 | GO:0017113 | dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
2.2 | 6.6 | GO:0008142 | oxysterol binding(GO:0008142) |
2.2 | 32.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
2.2 | 10.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.2 | 19.4 | GO:0015232 | heme transporter activity(GO:0015232) |
2.1 | 4.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.1 | 12.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.1 | 6.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
2.1 | 54.7 | GO:0070840 | dynein complex binding(GO:0070840) |
2.1 | 6.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.1 | 8.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
2.0 | 24.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.0 | 16.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.0 | 5.9 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
2.0 | 7.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.0 | 43.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.9 | 15.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
1.8 | 22.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
1.8 | 23.2 | GO:0098919 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
1.8 | 14.2 | GO:0008430 | selenium binding(GO:0008430) |
1.8 | 7.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.8 | 7.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.7 | 12.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.7 | 54.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.7 | 24.0 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.7 | 5.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.7 | 6.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.7 | 3.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
1.7 | 10.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.7 | 6.8 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
1.7 | 5.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.7 | 8.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
1.6 | 6.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
1.6 | 8.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.6 | 11.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.6 | 12.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.5 | 12.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.5 | 12.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.5 | 20.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.5 | 13.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.5 | 7.4 | GO:0016936 | galactoside binding(GO:0016936) |
1.5 | 4.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.5 | 8.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.5 | 21.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.5 | 47.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.4 | 5.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.4 | 4.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.4 | 4.1 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.3 | 8.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.3 | 23.0 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.3 | 22.9 | GO:0071949 | FAD binding(GO:0071949) |
1.3 | 3.8 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
1.3 | 25.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.2 | 2.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.2 | 3.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.2 | 20.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.2 | 5.9 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
1.2 | 24.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.2 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.1 | 47.0 | GO:0070330 | aromatase activity(GO:0070330) |
1.1 | 3.4 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.1 | 4.4 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
1.1 | 13.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.1 | 7.4 | GO:0031433 | telethonin binding(GO:0031433) |
1.0 | 10.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.0 | 6.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.0 | 4.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.0 | 5.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
1.0 | 5.9 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 10.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.0 | 2.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.0 | 11.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.0 | 3.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
1.0 | 3.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.9 | 25.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.9 | 3.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.9 | 6.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.9 | 3.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 2.6 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.9 | 9.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 2.6 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.9 | 4.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.9 | 2.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.9 | 32.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.9 | 4.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 17.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.8 | 3.3 | GO:0016160 | amylase activity(GO:0016160) |
0.8 | 5.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.8 | 3.2 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.8 | 3.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.8 | 3.2 | GO:0070697 | activin receptor binding(GO:0070697) |
0.8 | 7.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.8 | 11.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 11.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.8 | 2.3 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 12.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.8 | 2.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.8 | 0.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.8 | 7.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 5.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 6.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 2.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 3.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 4.3 | GO:0070061 | fructose binding(GO:0070061) |
0.7 | 1.4 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.7 | 4.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.7 | 5.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 2.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.7 | 13.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.7 | 5.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.7 | 5.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 3.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.6 | 2.6 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 3.2 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.6 | 4.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.6 | 3.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.6 | 3.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 1.9 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.6 | 4.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 10.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 3.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.6 | 6.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 3.7 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.6 | 4.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 1.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.6 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.6 | 5.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 6.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.6 | 20.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 15.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 12.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 2.7 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
0.5 | 28.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 2.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.5 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 2.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 4.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 1.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.5 | 2.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 8.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 2.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 2.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 31.5 | GO:0051287 | NAD binding(GO:0051287) |
0.5 | 1.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.5 | 3.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 7.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 7.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.5 | 6.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 3.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 1.4 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.5 | 33.0 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.5 | 0.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 9.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 53.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 2.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.4 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.4 | 0.9 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 2.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 4.4 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 0.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 6.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 2.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.4 | 7.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 1.2 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.4 | 1.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.4 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 2.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.4 | 3.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 0.4 | GO:0033041 | sweet taste receptor activity(GO:0033041) |
0.4 | 1.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 3.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 3.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 82.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 3.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.4 | 1.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 1.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 30.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 4.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 2.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 4.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 2.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 5.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 6.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 10.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 1.0 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.3 | 1.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 2.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 0.9 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.3 | 4.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 3.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 4.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 3.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 8.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 2.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 2.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 2.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 4.6 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 5.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 25.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 1.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 4.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 1.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 5.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 3.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 5.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 3.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 3.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 2.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 8.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 2.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 2.2 | GO:0016668 | thioredoxin-disulfide reductase activity(GO:0004791) oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 1.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 3.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 1.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.7 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.2 | 4.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.2 | 0.6 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 3.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 5.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 1.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.8 | GO:0000829 | inositol heptakisphosphate kinase activity(GO:0000829) |
0.2 | 1.0 | GO:0016723 | cupric reductase activity(GO:0008823) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 2.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 6.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 20.0 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.2 | 10.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 3.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 12.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 9.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.6 | GO:0052723 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 2.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.1 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 4.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 2.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 2.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 13.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 22.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 2.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 2.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.5 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
0.1 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 8.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 1.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 3.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 16.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 14.4 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 1.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 8.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 1.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 3.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 4.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 2.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 8.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.1 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 4.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 1.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 1.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 1.4 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 52.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 1.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.0 | 3.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0019809 | spermidine binding(GO:0019809) |
0.0 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 0.1 | GO:0071723 | lipoteichoic acid binding(GO:0070891) lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 11.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 19.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 131.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 28.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 0.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 7.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 4.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 7.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 5.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 8.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 5.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 9.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 5.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 6.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 6.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 6.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 8.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 2.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 10.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
3.5 | 89.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
3.4 | 50.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
3.3 | 42.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
2.8 | 8.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.6 | 44.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.3 | 43.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
2.2 | 47.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
2.1 | 23.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.1 | 12.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.0 | 16.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.0 | 32.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.8 | 35.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.7 | 19.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.7 | 24.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.7 | 3.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.6 | 12.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.5 | 19.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.5 | 43.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.4 | 11.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.4 | 26.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.4 | 15.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.3 | 37.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.3 | 21.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.2 | 69.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.2 | 4.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.2 | 1.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.1 | 20.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.1 | 6.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.1 | 12.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 25.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.0 | 54.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.9 | 26.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 31.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 13.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.9 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.9 | 151.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.9 | 11.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.8 | 18.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.8 | 12.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.8 | 28.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.8 | 14.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 10.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 19.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.7 | 25.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 24.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 7.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.6 | 3.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 5.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 9.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.6 | 15.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 3.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 7.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.5 | 4.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 23.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 3.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.5 | 10.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.5 | 13.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 9.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 15.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 9.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 2.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 1.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 9.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 14.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 7.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 4.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 21.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 1.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 3.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 4.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 4.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 16.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 9.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 7.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 5.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 4.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 22.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 4.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 3.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 4.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 3.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 4.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 10.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 6.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 2.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 3.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.9 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 2.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 15.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 3.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |